Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1561–1584 of 9,916 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Procedures Clear all

Conditions: Stroke, Stroke, Acute, Brain Injury, Acute
Interventions: Umbilical Cord Blood, Placebo; Biological · Other
Lead sponsor: Joanne Kurtzberg, MD; Other
Eligibility: 18 Years to 90 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 6
States / cities: Aurora, Colorado • Gainesville, Florida • Atlanta, Georgia + 3 more

Conditions: Prostate Carcinoma
Interventions: Behavioral Intervention, Biospecimen Collection, Electronic Health Record Review, Genetic Counseling, Genetic Testing, Interview, Survey Administration; Behavioral · Procedure · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acquired Immunodeficiency Syndrome, HIV Infections
Interventions: Tailored Information Program for Safer Sex; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 29 Years
Enrollment: 274 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Low Grade Glioma, Malignant Brain Glioma, Malignant Brain Neoplasm, Meningioma
Interventions: Biospecimen Collection, Computed Tomography, Dexamethasone, Magnetic Resonance Imaging, Questionnaire Administration; Procedure · Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Stage I Papillary Thyroid Cancer, Stage II Papillary Thyroid Cancer, Stage III Papillary Thyroid Cancer
Interventions: Thyroidectomy, entral lymph node dissection (CLND), Quality-of-life assessment; Procedure · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years to 73 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Asthma in Children
Interventions: CASE Program, HARP Program; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 2 Years to 12 Years
Enrollment: 432 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Neoplasms, Chemotherapy-induced Nausea and Vomiting
Interventions: eSSET-CINV; Behavioral
Lead sponsor: University of Central Florida; Other
Eligibility: 60 Years and older
Enrollment: 610 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Miami, Florida • Orlando, Florida

Conditions: Forehead; Wound
Interventions: Group 1 cannabidiol (CBD) with silicone ointment, Group 2 silicone patch; Biological
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Rosacea
Interventions: brimonidine topical gel 0.33% & survey, brimonidine topical gel 0.33% & SOC; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Necrotizing Fascitis, Necrotizing Soft Tissue Infection
Interventions: Cytal® Wound Matrix, MicroMatrix®; Device
Lead sponsor: Benjamin T. Miller; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Primary Aldosteronism
Interventions: Adrenalectomy, mineralocorticoid receptor antagonist; Other · Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: HIV/AIDS
Interventions: The BRIDGES Project Intervention; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: San Diego, California

Conditions: Overweight and Obesity
Interventions: Nutrigenomix, personalized dietary plan, Physical Activity, Behavioral counseling, Standard Dietary plan; Behavioral
Lead sponsor: Augusta University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Adverse Pregnancy Outcome
Interventions: Lovenox 40mg; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Cardiovascular Disease
Interventions: control group, Lifestyle management; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Overweight and Obesity, Pediatric Obesity, Eating, Binge
Interventions: Pathways to Health, Be4U; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 13 Years to 18 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Pleural Effusion Associated With Pulmonary Infection, Pleural Effusion Disorder, Pleural Effusions
Interventions: Pleural Saline Irrigation; Combination Product
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Age-related Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema
Interventions: Povidone Iodine, Hypochlorous Acid; Other
Lead sponsor: California Retina Consultants; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Critical Illness
Interventions: Participation in PFCC-IR; Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 80 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Obesity
Interventions: Macronutrient Modification; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 7 Years to 11 Years · Female only
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Opioid Use Disorder, Chronic Pain
Interventions: Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP), Enhance Usual Care (EUC); Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Albuquerque, New Mexico

Conditions: Bell's Palsy, Facial Nerve Paresis
Interventions: Intratympanic injection, Prednisone; Procedure · Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Esophageal Carcinoma, Lung Carcinoma, Malignant Head and Neck Neoplasm, Malignant Solid Neoplasm
Interventions: Best Practice, Quality-of-Life Assessment, Questionnaire Administration, Yoga; Other · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Aging
Interventions: Transcranial direct current stimulation (tDCS), Sham stimulation, Behavioral intervention to increase physical activity; Device · Behavioral
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 65 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Roslindale, Massachusetts

Search by objective public record fields.

Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer

Rhode Island Asthma Integrated Response Program

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Topical CBD Scar Outcomes Study

Internet Surveys and Their Impact on Adherence for Rosacea

The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®

Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas

The BRIDGES Project: Bridging Resources to Engage Women in Integrated HIV Care and Support Services

Lifestyle Intervention for Healthy Change

Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project

PREDHICT: Precision Recruitment and Engagement of Diabetics and Hypertensives in Clinical Studies

Evaluating the Feasibility of a Stepped-care Approach to Treating Adolescents With Binge and Loss of Control Eating

Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections [LYTICS +]

Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study)

Developing and Testing a Nurse-Led Technology-Enhanced Family Engagement Program

Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)

Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial

Intratympanic Steroid for Bell's Palsy

Yoga Program for Improving the Quality of Life in Couples Coping With Cancer

Modulating Brain Activity to Improve Goal-directed Physical Activity in Older Adults